Trends in Bio/Pharmaceutical Industry (TBI) is a scientific journal focused on the latest discoveries, innovations, development and trends in the various fields of life sciences, especially in research institutes and pharmaceutical and biotechnology industry. Authors of TBI are mostly, but not limited to, scientific, legal and financial professional and entrepreneurs in US with Chinese heritage. The targeted readers of TBI are researchers, scientists, entrepreneurs and senior managers in biopharmaceutical industry. TBI is published quarterly both online and in hard copies.
TBI is the official journal of the Alliance of Chinese-American Biotechnology and Pharmaceutical Associations (ALL-CABPA), an alliance of 5 nonprofit organizations comprising of Chinese-American Bio/pharmaceutical Society (CABS) in San Francisco Bay Area, Sino-American Biomedical and Pharmaceutical Professionals Association (SABPA) in San Diego and Los Angeles area, Chinese Biopharmaceutical Association (CBA) in Maryland, Chinese-American BioMedical Association (CABA) in Boston area, and Seattle Chinese Biomedical Assocation (SCBA) at Seattle area. In addition, Bayhelix, an organization for business and legal professionals, is also participated in publication of TBI.
The participating organizations cover the major biotechnology and biopharmaceutical industrial hubs in US with a total of over 10 thousand members from the West Coast to the East Coast of US, as well as in China.
TBI also partners with leading Pharmaceutical Journals in China and distributes its online version to readers in China as well.